Should Compliance have an "on-line" or "off-line" role?
Alicia Whittlesey
Compliance simplified.
Latest Publications
Alicia Whittlesey
Pharmaceutical Executive The Department of Justice is Watching: Building a Data-Driven Compliance Program
HHS-OIG Focuses on Speaker Programs with Special Fraud Alert
Device Company Settles Open Payment Program Reporting Violation, Agrees to Pay Over $9.2 Million
FDA Clarifies Types of Evidence Relevant to Determining the "Intended Use" of a Product
Massachusetts Department of Public Health Extends Pharmaceutical and Medical Device Manufacturer Registration Renewal Deadline in Response to COVID-19 Pandemic
U.S. Court of Appeals, D.C. Circuit Upholds Decision Against Drug Pricing Rule
John Patrick Oroho Interview with Global Business Reports US Biopharmaceuticals 2020
John Oroho
Utah Insurance Department Issues Bulletin Regarding Prescription Drug Price Transparency Act; Contact Information Due June 1, 2020
Communication During a Pandemic
Alicia Whittlesey
1-10 of 70